Citation

Toutah K, Nawar N, Timonen S, Sorger H, Raouf YS, Bukhari S, von Jan J, Ianevski A, Gawel JM, Olaoye OO, Geletu M, Abdeldayem A, Israelian J, Radu TB, Sedighi A, Bhatti MN, Hassan MM, Manaswiyoungkul P, Shouksmith AE, Neubauer HA, de Araujo ED, Aittokallio T, Krämer OH, Moriggl R, Mustjoki S, Herling M, Gunning PT.: Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia. J Med Chem, Volume 64 (12), 2021

Authors

Abdeldayem A, Aittokallio T, Bhatti MN, Bukhari S, de Araujo ED, Gawel JM, Geletu M, Gunning PT., Hassan MM, Herling M, Ianevski A, Israelian J, Krämer OH, Manaswiyoungkul P, Moriggl R, Mustjoki S, Nawar N, Neubauer HA, Olaoye OO, Radu TB, Raouf YS, Sedighi A, Shouksmith AE, Sorger H, Timonen S, Toutah K, von Jan J

Journal

J Med Chem

Year

2021

DOI

10.1021/acs.jmedchem.1c00420

PubMed

34101461

Machine-readable

REST APIRDF